Potential role of indoleamine 2,3-dioxygenase in primary biliary cirrhosis

Citation metadata

From: Oncology Letters(Vol. 14, Issue 5)
Publisher: Spandidos Publications
Document Type: Report
Length: 5,476 words
Lexile Measure: 1230L

Document controls

Main content

Abstract :

Indoleamine 2,3-dioxygenase (IDO)-induced immunosuppression can be clinically beneficial for autoimmune diseases. Primary biliary cirrhosis (PBC) is characterized by autoimmune lesions of intrahepatic bile duct epithelial cells that may lead to irreversible cirrhosis or hepatocellular carcinoma. The present study assessed the expression and function of IDO in a cell culture model and in PBC patients. IDO expression was monitored in a human immortalized but non-malignant biliary epithelial cell (iBEC) line. Increased expression of IDO1/2 was observed in the iBECs following stimulation with interferon-[gamma] (IFN-[gamma]). The induction of IDO was IFN-[gamma]-dependent, but was independent of the transforming growth factor-[beta] (TGF-[beta]) pathway. IDO enzymatic activity was observed in the supernatant of iBECs following stimulation with IFN-[gamma] using colorimetric assays. A total of 47 serum samples from PBC patients were used to examine IDO activity by high-performance liquid chromatography, with samples from 24 healthy volunteers used as controls. Patients with PBC exhibited an increased rate of tryptophan to kynurenine conversion (P 0.01). Liver sections from patients with PBC (n=5) and those of healthy controls (n=5) were used for immunohistochemical studies. IDO expression was observed in biliary epithelial cells and in hepatocytes of PBC patients. Finally, the effect of tryptophan metabolites on human cluster of differentiation (CD) [4.sup.+] T cells in inducing polarization towards a regulatory T cell phenotype was examined. 3-Hydroxykynurenine significantly upregulated the fraction of CD[4.sup.+] cells expressing forkhead box p3 (Foxp3). The results of the present study suggest a therapeutic opportunity for the management of PBC and indicate that tryptophan catabolism could serve as a potential biomarker to monitor disease progression.

Source Citation

Source Citation   

Gale Document Number: GALE|A523918196